A gel that delivers a new treatment for diabetic foot ulcers
Cutaneous Gel Delivering an Intriguing MOA Therapeutic to Treat DFU
This study is testing a special gel that helps deliver a medicine to speed up the healing of diabetic foot ulcers, which are painful sores that can happen to people with diabetes.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lynntech, INC. NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10921751 on NIH RePORTER |
What this research studies
This research focuses on developing a specialized gel that can deliver a small molecule therapeutic aimed at improving the healing of diabetic foot ulcers (DFUs). DFUs are a serious complication of diabetes that can lead to severe health issues, including amputations. The gel is designed for controlled delivery of the therapeutic, which has a unique mechanism of action to enhance healing. By addressing the challenges of current DFU treatments, this project aims to provide a more effective solution for patients suffering from this debilitating condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetic foot ulcers who are struggling with current treatment options.
Not a fit: Patients without diabetes or those who do not have diabetic foot ulcers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective treatment for diabetic foot ulcers, potentially reducing the need for amputations and improving patient quality of life.
How similar studies have performed: Previous research has shown promise in using controlled delivery systems for therapeutic agents, indicating potential success for this novel approach.
Where this research is happening
College Station, United States
- Lynntech, INC. — College Station, United States (Active)
Researchers
- Principal investigator: Sharma, Anjal C — Lynntech, INC.
- Study coordinator: Sharma, Anjal C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.